<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Beghi E</submitter><funding>World Health Organization</funding><pagination>2265-2274</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8528941</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>269(5)</volume><pubmed_abstract>Acute and post-acute neurological symptoms, signs and diagnoses have been documented in an increasing number of patients infected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which causes Coronavirus Disease 2019 (COVID-19). In this review, we aimed to summarize the current literature addressing neurological events following SARS-CoV-2 infection, discuss limitations in the existing literature and suggest future directions that would strengthen our understanding of the neurological sequelae of COVID-19. The presence of neurological manifestations (symptoms, signs or diagnoses) both at the onset or during SARS-CoV-2 infection is associated with a more severe disease, as demonstrated by a longer hospital stay, higher in-hospital death rate or the continued presence of </pubmed_abstract><journal>Journal of neurology</journal><pubmed_title>Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions.</pubmed_title><pmcid>PMC8528941</pmcid><funding_grant_id>001</funding_grant_id><pubmed_authors>Frontera J</pubmed_authors><pubmed_authors>Westenberg E</pubmed_authors><pubmed_authors>Kivipelto M</pubmed_authors><pubmed_authors>Prasad K</pubmed_authors><pubmed_authors>Garcia-Azorin D</pubmed_authors><pubmed_authors>Mangialasche F</pubmed_authors><pubmed_authors>Mukaetova-Ladinska EB</pubmed_authors><pubmed_authors>Allegri R</pubmed_authors><pubmed_authors>Chowdhary N</pubmed_authors><pubmed_authors>Winkler AS</pubmed_authors><pubmed_authors>Beghi E</pubmed_authors><pubmed_authors>Guekht A</pubmed_authors><pubmed_authors>Giussani G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Acute and post-acute neurological manifestations of COVID-19: present findings, critical appraisal, and future directions.</name><description>Acute and post-acute neurological symptoms, signs and diagnoses have been documented in an increasing number of patients infected by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which causes Coronavirus Disease 2019 (COVID-19). In this review, we aimed to summarize the current literature addressing neurological events following SARS-CoV-2 infection, discuss limitations in the existing literature and suggest future directions that would strengthen our understanding of the neurological sequelae of COVID-19. The presence of neurological manifestations (symptoms, signs or diagnoses) both at the onset or during SARS-CoV-2 infection is associated with a more severe disease, as demonstrated by a longer hospital stay, higher in-hospital death rate or the continued presence of </description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 May</publication><modification>2025-05-18T12:29:45.207Z</modification><creation>2025-05-18T12:29:45.207Z</creation></dates><accession>S-EPMC8528941</accession><cross_references><pubmed>34674005</pubmed><doi>10.1007/s00415-021-10848-4</doi></cross_references></HashMap>